Exp Mol Med.  2008 Jun;40(3):345-353. 10.3858/emm.2008.40.3.345.

Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2

Affiliations
  • 1Institute for Brain Science and Technology, Inje University , Busan 614-735, Korea. wseol@inje.ac.kr
  • 2Juseong Gene Therapy R&D Center, Department of Biotechnology, Juseong College, Chungbuk 363-794, Korea.
  • 3Korean Research Institute of Bioscience and Biotechnology, Daejun 305-333, Korea.
  • 4Department of Pathology, Inje Medical School, Busan 614-735, Korea.
  • 5School of Engineering, University of Suwon, Suwon 445-743, Korea.
  • 6College of Medicine and Institute for Tumor Research, Chungbuk National University, Chungbuk 361-763, Korea.

Abstract

For cancer gene therapy, cancer-specific over-expression of a therapeutic gene is required to reduce side effects derived from expression of the gene in normal cells. To develop such an expression vector, we searched for genes over-expressed and/or specifically expressed in cancer cells using bioinformatics and have selected genes coding for protein regulator of cytokinesis 1 (PRC1) and ribonuclease reductase 2 (RRM2) as candidates. Their cancer-specific expressions were confirmed in both breast cancer cell lines and patient tissues. We compared each promoter's cancer-specific activity in the breast normal and cancer cell lines using the luciferase gene as a reporter and confirmed cancer-specific expression of both PRC1 and RRM2 promoters. To test activities of these promoters in viral vectors, the promoters were also cloned into an adeno-associated viral (AAV) vector containing green fluorescence protein (GFP) as the reporter. The GFP expression levels by these promoters were various depending on cell lines tested and, in MDA-MB-231 cells, GFP activities derived from the PRC1 and RRM2 promoters were as strong as that from the cytomegalovirus (CMV) promoter. Our result showed that a vector containing the PRC1 or RRM2 promoter could be used for breast cancer specific overexpression in gene therapy.

Keyword

breast neoplasms; gene therapy; PRC1 protein, human; ribonucleotide reductase M2

MeSH Terms

Breast Neoplasms/*genetics/therapy
Cell Cycle Proteins/*genetics/metabolism
Cell Line, Tumor
Cloning, Molecular
Cytomegalovirus
Dependovirus
Female
*Gene Targeting
Gene Therapy
Genetic Vectors
Green Fluorescent Proteins
Humans
Promoter Regions, Genetic/*genetics
Ribonucleoside Diphosphate Reductase/*genetics/metabolism
*Transcriptional Activation
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr